{"id":"https://genegraph.clinicalgenome.org/r/c8daffcc-6fb5-4b3b-b635-0a0d2123ef88v1.0","type":"EvidenceStrengthAssertion","dc:description":"The neuronal ceroid lipofuscinoses (NCL) are a heterogeneous group of progressive neurodegenerative disorders characterized by the intracellular accumulation of auto-fluorescent storage material.   Biallelic pathogenic variants in CTSD are causative of neuronal ceroid lipofuscinosis, type 10 (NCL10).  NCL10 is characterized by acquired microcephaly, developmental regression, seizures, ataxia, cardiomyopathy and retinitis pigmentosa.  Onset of symptoms can range from the prenatal period to the second decade and affected individuals demonstrate cerebral and cerebellar atrophy on MRI, significantly reduced cathepsin D enzyme activity in leukocytes or fibroblasts and the characteristic autofluorescent storage bodies in a variety of cell types.  The disease mechanism is loss of function and CTSD mutations result in a significantly reduced cathepsin D, a lysosomal aspartyl proteinase essential to neuronal cell homeostasis. Over 10 different disease-causing mutations reported in families in the literature, the majority of which are homozygous variants identified in consanguineous families.  The mutation spectrum includes nonsense, frameshift, and missense variants (Doccini et al, PMID 27072142;  Steinfeld et al, PMID 16685649;  Thottath et al, PMID 31086824;  Hersheson et al, PMID 25298308;  Fokstuen et al, PMID 27353043;  Varvagiannis et al, PMID 29284168;  Meyer et al, PMID 26059544;  Komlosi et al, PMID 29373990;  Sintola et al, PMID 16670177;  Seidahmed et al, PMID 23101555;  Alazami et al, PMID 25558065; Shaheen et al, PMID 30214071;  Fritchie et al, PMID 18762956;  Santorelli et al, PMID 23374165).  Missense variant point assignment was upgraded due to functional data and/or the presence of the variant in individuals with proven reduced cathepsin D enzyme activity.  Additionally, a number of reported families demonstrate complete co-segregation in affected and unaffected individuals.  Supporting experimental evidence includes functional alteration in non-patient cells (Paranen et al, PMID 12350228),  expression (Reid et al, 3543065),  non-human model organism (Tyynela et al, 10856224 ;  Koike et al, 10995834 ; Awano et al, 16386934), and rescue in non-human model organism (Marques et al, 31282275).   A genetic evidence score of 12 and experimental evidence score of 5 results in a total score of 17.  Evidence supporting an association between CTSD and NCL has been replicated over time; therefore, the gene-disease validity has been classified as DEFINITIVE.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/c8daffcc-6fb5-4b3b-b635-0a0d2123ef88","GCISnapshot":"https://genegraph.clinicalgenome.org/r/d74b1b2a-52a3-4192-b5b4-e4fd46ffc0ba","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/d74b1b2a-52a3-4192-b5b4-e4fd46ffc0ba_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2020-11-03T18:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/d74b1b2a-52a3-4192-b5b4-e4fd46ffc0ba_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2020-11-03T17:54:32.530Z","role":"Publisher"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d74b1b2a-52a3-4192-b5b4-e4fd46ffc0ba_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0576b479-08ad-4fa4-9770-616d4826623d_proband_score_evidence_line","type":"EvidenceLine","dc:description":"homozygous, no functional data","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/23dc3357-2e61-4fd5-b7a0-a9d2554a5546","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23374165","rdfs:label":"Patient 1","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"Sanger sequencing","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/0576b479-08ad-4fa4-9770-616d4826623d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23374165","allele":{"id":"https://genegraph.clinicalgenome.org/r/93786faf-f2d6-4950-9b73-00dc351b81c4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001909.5(CTSD):c.944T>A (p.Ile315Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379093636"}}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/1a4e8412-7b70-4905-a33a-a29e3c567e79_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd6da45a-ab5c-483b-bded-f6f34414561e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18762956","rdfs:label":"Patient 1","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Poor neonatal respiratory effort, seizure like activity immediately after birth, hypertonia, microcephaly.  Generalized hypoplasia of cerebral hemispheres and cerebellum.  Death on DOL 2. Autopsy revealed extensive neuronal loss and storage material noted in brain tissue positive for sphingolipid activator protein D with GRODs","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/1a4e8412-7b70-4905-a33a-a29e3c567e79_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18762956","allele":{"id":"https://genegraph.clinicalgenome.org/r/462a8b0a-0ebd-4343-a677-ca9463935a65","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001909.5(CTSD):c.299C>T (p.Ser100Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA314368"}}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/9ec4e77c-1875-451c-8e68-7e5b13112b12_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/249d86b4-8708-4233-9c3e-528983de9fd8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16670177","rdfs:label":"Patient 3","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"microcephaly, intractable neonatal seizures, spasticity and apnea","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/9ec4e77c-1875-451c-8e68-7e5b13112b12_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16670177","allele":{"id":"https://genegraph.clinicalgenome.org/r/f0044c29-057d-4334-bb64-52a930b32955","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001909.5(CTSD):c.764dup (p.Tyr255Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA258043"}}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/0dbc5a4b-9dfc-4731-bebf-9a4140c9338f_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1c8e3ebe-5a05-40da-a8f4-f06a2585b76d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16685649","rdfs:label":"Patient 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":17,"detectionMethod":"","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Normal early development, onset early school age with ataxia and visual disturbances, retinitis pigmentosa. MRI found cerebral and cerebellar atrophy.  Progressive cog decline and loss of speech, at 17 WC bound with severe ID.  GROD and myelin like lamellar structures found on skin bx","previousTesting":true,"previousTestingDescription":"Sequenced CTSD, CLN3, CLN5, CLN6 and CLN8.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/0dbc5a4b-9dfc-4731-bebf-9a4140c9338f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16685649","allele":[{"id":"https://genegraph.clinicalgenome.org/r/a213f454-19d1-48e5-bfff-3da176d9b419","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001909.5(CTSD):c.685T>A (p.Phe229Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA258041"}},{"id":"https://genegraph.clinicalgenome.org/r/9a1a3067-54a9-4638-b439-bd9f90fb2ed2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001909.5(CTSD):c.1149G>C (p.Trp383Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA258042"}}]}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/53f18d4d-6e5b-4d2d-b51f-7295f133a5e4_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ee30f287-6aa8-456d-b650-c9fa7e7e3ac7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27072142","rdfs:label":"Patient 1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":2,"detectionMethod":"","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Deceleration of head growth, marked cerebral atrophy, severely progressive epilepsy at 18 mos, GRODs in skin and HCM.  Developmental regression at 5 mos. Profound global delay, axial hypotonia, tetraparetic, hypotonic limbs, visual impairment.","previousTesting":true,"previousTestingDescription":"PPT1 enzyme, sequencing, and mRNA expression normal.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/53f18d4d-6e5b-4d2d-b51f-7295f133a5e4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27072142","allele":{"id":"https://genegraph.clinicalgenome.org/r/6caa15ca-b581-445c-9b0c-be274ba4513f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001909.5(CTSD):c.205G>A (p.Glu69Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA216180802"}}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d7bde399-c341-43c4-9859-76868cc510e5_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7ae86bfe-b848-4094-b110-9c5d08228819","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27353043","rdfs:label":"Patient 41","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"225 gene encephalopathy panel","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"Neonatal encephalopathy; consanguineous parents, poor Apgars 2/2/3, required intubation.  Axial hypotonia and limb hypertonia, seizures at 4 hrs of life.  MRI massive and severe shrinking of cerebrum and cerebellum","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/d7bde399-c341-43c4-9859-76868cc510e5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27353043","allele":{"id":"https://genegraph.clinicalgenome.org/r/a213f454-19d1-48e5-bfff-3da176d9b419"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/7c73951d-81a7-41d1-9ff7-0f2755fdf99b_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8b3d47e0-8d2b-4079-a2c5-4e28cb9b057c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25298308","rdfs:label":"B:3","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":8,"detectionMethod":"","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Ataxia, retinitis pigmentosa, cognitive decline","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/7c73951d-81a7-41d1-9ff7-0f2755fdf99b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25298308","allele":{"id":"https://genegraph.clinicalgenome.org/r/8a512aa6-815b-4acc-be73-55ba31d78a14","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001909.5(CTSD):c.1196G>A (p.Arg399His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA276038"}}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/b699fc98-f8e4-40b4-96c0-b64761d4fb0f_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Homozygous, no functional data.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8d36a842-e869-4924-96a9-1c336d5cc9f5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23101555","rdfs:label":"Patient 1","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"Exome sequencing","previousTesting":true,"previousTestingDescription":"Homozygosity mapping","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/b699fc98-f8e4-40b4-96c0-b64761d4fb0f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23101555","allele":{"id":"https://genegraph.clinicalgenome.org/r/1a4e4f03-9916-48d6-ab54-7dd60d13a41b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001909.5(CTSD):c.1155_1169dup (p.Ile390_Gly391insMetGlyAspValPhe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA186052"}}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/88424203-a467-4044-b560-9e89920b4f58_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c0d889be-104a-48cd-8bad-8b15d2b2897c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25298308","rdfs:label":"A:3","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":15,"detectionMethod":"","firstTestingMethod":"Homozygosity mapping","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Exome sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/88424203-a467-4044-b560-9e89920b4f58_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25298308","allele":{"id":"https://genegraph.clinicalgenome.org/r/5c39b012-4a20-4aee-95e7-ab9b321846ca","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001909.5(CTSD):c.446G>T (p.Gly149Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA276036"}}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/3b8e5875-4cab-44af-8bb9-aec998aeefd0_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a56ba525-e682-4f97-861b-2b496be21c82","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26059544","rdfs:label":"Patient 1","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"Sanger sequencing","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/3b8e5875-4cab-44af-8bb9-aec998aeefd0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26059544","allele":{"id":"https://genegraph.clinicalgenome.org/r/d624a931-8e06-4e63-bbe0-5dc5206b89c5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001909.5(CTSD):c.268dup (p.Gln90fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA5814243"}}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/09c41a09-bcb7-483d-b6dd-64d690bdd6e5_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Homozygous, no functional data","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/15937fd3-884a-436d-b2fc-b6b266826cec","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31086824","rdfs:label":"II-2","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":3,"detectionMethod":"","firstTestingMethod":"Exome sequencing","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/09c41a09-bcb7-483d-b6dd-64d690bdd6e5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31086824","allele":{"id":"https://genegraph.clinicalgenome.org/r/903ee34e-21a4-443c-b770-fc259f16bd95","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001909.5(CTSD):c.392A>G (p.Tyr131Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA5814188"}}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/d74b1b2a-52a3-4192-b5b4-e4fd46ffc0ba_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7306bbfc-0f51-412a-84ea-daf708a9c0b4_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26059544","rdfs:label":"Family 1","estimatedLodScore":1.33,"family":{"id":"https://genegraph.clinicalgenome.org/r/7306bbfc-0f51-412a-84ea-daf708a9c0b4","type":"Family","rdfs:label":"Family 1","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/a56ba525-e682-4f97-861b-2b496be21c82"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"","phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/a56ba525-e682-4f97-861b-2b496be21c82"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/30916f3d-514b-4410-b203-ff58aa4e3d77_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25298308","rdfs:label":"Family A","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/30916f3d-514b-4410-b203-ff58aa4e3d77","type":"Family","rdfs:label":"Family A","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/c0d889be-104a-48cd-8bad-8b15d2b2897c"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"","phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":4,"proband":{"id":"https://genegraph.clinicalgenome.org/r/c0d889be-104a-48cd-8bad-8b15d2b2897c"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/ec8ac3b5-db23-4644-97f2-ba9552d76c45_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31086824","rdfs:label":"Family 2","estimatedLodScore":0.73,"family":{"id":"https://genegraph.clinicalgenome.org/r/ec8ac3b5-db23-4644-97f2-ba9552d76c45","type":"Family","rdfs:label":"Family 2","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/15937fd3-884a-436d-b2fc-b6b266826cec"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"","phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/15937fd3-884a-436d-b2fc-b6b266826cec"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/562956b5-d76b-4989-be37-37e35d381c1a_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23101555","rdfs:label":"09DG00288","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/562956b5-d76b-4989-be37-37e35d381c1a","type":"Family","rdfs:label":"09DG00288","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/8d36a842-e869-4924-96a9-1c336d5cc9f5"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Severe microlissencephaly and hyperekplexia, microcephaly, hypertonia, arthrogryposis, optic atrophy, MRI/CT abnormalities (cerebral and cerebellar atrophy, simplified gyral pattern).  Death 4 days-6 weeks.","phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":4,"proband":{"id":"https://genegraph.clinicalgenome.org/r/8d36a842-e869-4924-96a9-1c336d5cc9f5"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":2.6}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/d74b1b2a-52a3-4192-b5b4-e4fd46ffc0ba_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d74b1b2a-52a3-4192-b5b4-e4fd46ffc0ba_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/819339c8-585e-4c10-9ac9-4c007fba9650","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b742be20-31b9-4c48-8520-19a5983481ee","type":"Finding","dc:description":"Similar phenotype, AR inheritance, reduced enzyme, pathology similarities in brain, presnece of GRODs","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10856224","rdfs:label":"Natural Ovine Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/fed97908-8a9b-4362-8b62-eedfa2254269","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/db433afa-eabc-453c-98ac-652dcba2eaf9","type":"Finding","dc:description":"Phenotypic overlap, autofluorescent storage material in brain and retina.  AR inheritance.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16386934","rdfs:label":"Natural American Bulldog Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/93407fc7-cc9c-430e-b9d2-3f47b2274bc3","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/afb6e12a-38f8-470b-8105-f19e0804c4be","type":"Finding","dc:description":"CD -/- studied.  Grow normally for 2 weeks then die found P26 from intestinal necrosis and reduced feeding.  Developed seizures at P20, in some cases severe TCS with death from respiratory arrest.  Mice also had eyelids almost closed, tests using box with light/dark regions suggest that mice were blind (controls would move to dark region which affected mice would not).  Brains were similar in size to controls.   In hippocampal slices prepared from CD−/− mice after P18, spontaneous burst discharges consisting of 4–15 population spikes superimposed on a prolonged positive deflection (60–150 msec) were recorded from the stratum pyramidale of both the CA1 and the CA3 regions. Neurons in CD−/− mouse brains after P20 possessed numerous granular structures, which varied in size, content, and electron density, in the perikarya and near the terminal stage (P23–P26) the neurons were completely filled with these granules","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10995834","rdfs:label":"Knock out Mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ade6db9b-e4ba-48ef-8ac7-f0329d42f3a4","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f1be6827-2c29-4d65-b34d-20ff63ec2644","type":"Finding","dc:description":"After repeat dosing, CTSD detectable in tissues analyzed.  CTSD activity and protein levels completely restored in liver and led to correction of pathological markers (LAMP1, HEXB levels).  Treatment led to reduction in accumulation of saposin C and SAPD in liver, kidneys, intestine, muscle and reversed vacuolization and presence of storage material in liver.  Only minor levels of CTSD found in CNS with the dosing regimen.  Treated CTSD null mice with rhCTSD via intracranial injection and found prior to sacrifice, mice had increased body weight, superior motor coordination and strength as compared to untreated litter mates.  Brain lysates demonstrated increased levels of CTSD activity of protein compared to untreated controls.  LAMP1 and HEXB protein levels restored to normal and storage material reduced in the brain. Microgliosis and astrogliosis were less pronounced in treated animals.  Injected rhCTSD in vitreous cavity of null mice.  Treatment did not delay retinal degeneration and photoreceptor loss but there was significant decrease in in CD68 positive microglia/macrophages, decrease in pathological markers and abrogation of SQSTM1/p62 puncta in retinas suggesting autophagy substrates were cleared.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31282275","rdfs:label":"Rescue in Null Mouse using Recombinant Human CTSD","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/d74b1b2a-52a3-4192-b5b4-e4fd46ffc0ba_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eeb324ef-df13-47d7-87f0-5c475c2e9cd1","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/170776a1-044f-4d96-9f2f-81d9859d09af","type":"FunctionalAlteration","dc:description":"Overexpression of mutant D293N mCTSD in HEK-293 cells completely inactivated enzyme and affected trafficking, processing and stability.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12350228","rdfs:label":"Overexpression of D293N Mutation in Mice"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d74b1b2a-52a3-4192-b5b4-e4fd46ffc0ba_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/62670d90-b428-4229-8f20-f4ee36e6e565","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/07500e72-d899-4944-82d0-2d452491f40b","type":"Finding","dc:description":"Immunocolocalization demonstrates expression in cerebral and cerebellar cortex","dc:source":"https://pubmed.ncbi.nlm.nih.gov/3543065","rdfs:label":"Immunocolocalization","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5}],"evidenceStrength":"Definitive","sequence":1413,"specifiedBy":"GeneValidityCriteria7","strengthScore":17,"subject":{"id":"https://genegraph.clinicalgenome.org/r/h_CVqwjSU_Q","type":"GeneValidityProposition","disease":"obo:MONDO_0016295","gene":"hgnc:2529","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_d74b1b2a-52a3-4192-b5b4-e4fd46ffc0ba-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}